ask="N/A"
ask_size="N/A"
average_daily_volume="33656"
bid="2.00"
bid_size="100"
book_value="0.49"
change="-0.12"
change_from_200_day_moving_average="-0.83"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-6.14"
change_From_52_week_low="0.06"
change_in_percent="-4.02%"
close="2.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="5060000"
high="3.15"
high_52_weeks="9.00"
last_trade_date="2/2/2017"
last_trade_price="2.86"
last_trade_size="133"
last_trade_time="4:00pm"
low="2.83"
low_52_weeks="2.80"
market_capitalization="23.96M"
moving_average_200_day="3.69"
moving_average_50_day="3.47"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="2.98"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.59%"
percent_change_from_50_day_moving_average="-17.67%"
percent_change_from_52_week_high="-68.22%"
percent_change_from_52_week_low="+2.14%"
previous_close="2.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.03"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.29"
stock_exchange="NCM"
symbol="VTGN"
volume="13347"
weeks_range_52="2.80 - 9.00"
